PDS Biotechnology Files 8-K for Other Events

Ticker: PDSB · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1472091

Pds Biotechnology Corp 8-K Filing Summary
FieldDetail
CompanyPds Biotechnology Corp (PDSB)
Form Type8-K
Filed DateFeb 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, corporate-events

TL;DR

PDS Biotech filed an 8-K on Feb 26, 2025, for 'Other Events' - details TBD.

AI Summary

PDS Biotechnology Corporation filed an 8-K on February 26, 2025, to report other events and financial statements. The filing indicates a change in the company's status or operations, though specific details of the events are not provided in this excerpt. The company, formerly known as Edge Therapeutics, Inc., is incorporated in Delaware and headquartered in Princeton, NJ.

Why It Matters

This 8-K filing signals that PDS Biotechnology has reported significant events or changes that could impact its business operations or financial standing, requiring disclosure to investors.

Risk Assessment

Risk Level: medium — An 8-K filing for 'Other Events' can cover a wide range of disclosures, some of which may be material and impact the company's stock price.

Key Numbers

  • 001-37568 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 26-4231384 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • PDS Biotechnology Corporation (company) — Registrant
  • Edge Therapeutics, Inc. (company) — Former Company Name
  • February 26, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • Princeton, NJ (location) — Principal Executive Offices

FAQ

What specific 'Other Events' are being reported by PDS Biotechnology Corporation in this 8-K filing?

The provided excerpt does not detail the specific 'Other Events' being reported; it only indicates that this item is being addressed in the filing.

When was PDS Biotechnology Corporation formerly known as Edge Therapeutics, Inc.?

The company's name was changed from Edge Therapeutics, Inc. on September 11, 2009.

Where are PDS Biotechnology Corporation's principal executive offices located?

The principal executive offices are located at 303A College Road East, Princeton, NJ 08540.

What is the SIC code for PDS Biotechnology Corporation?

The Standard Industrial Classification (SIC) code for PDS Biotechnology Corporation is 2834, which corresponds to Pharmaceutical Preparations.

What is the fiscal year end for PDS Biotechnology Corporation?

The company's fiscal year ends on December 31.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding PDS Biotechnology Corp (PDSB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.